Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Digital Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Market Overview:

The global digital therapeutics market reached a value of US$ 4.2 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 13.4 Billion by 2027, exhibiting a CAGR of 21.7% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor. 

Digital therapeutics (DTx) deliver evidence-based therapeutic interventions to patients. They aid in enhancing the existing medical treatments, providing therapy solutions, and reducing reliance on pharmaceuticals using high-quality software programs. They also prevent, manage and treat physical, mental, and behavioral health and find application in diagnosing conditions like Alzheimer’s disease, type II diabetes, and respiratory disorders, such as asthma, gastrointestinal problems, and chronic obstructive pulmonary disease. At present, there is a significant rise in the demand for DTx as they reduce health care costs and support the overall health of patients.

 

 
 

www.imarcgroup.com

Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.

To get more information about this market, Request Sample

Digital Therapeutics Market Trends:

The boosting sales of smart devices like mobile phones and tablets, rising internet penetration and the increasing number of healthcare applications are among the major factors strengthening the growth of the market. DTx finds application in a diverse range of neuroscience indications, such as autism spectrum disorder (ASD), attention deficit hyperactivity disorder (ADHD), depression, schizophrenia, and bipolar disease. Additionally, the rising prevalence of chronic diseases like diabetes and obesity, along with the increasing need for controlling costs of healthcare treatments, are supporting the growth of the market. Furthermore, pharmaceutical companies around the world are investing and engaging in strategic partnerships to expand their product portfolio and market reach. They are also focusing on providing patients with information concerning different conditions and subsequent treatments as well as organizing, tracking, and self-managing their diseases. These initiatives undertaken by pharmaceutical companies are anticipated to impel the growth of the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global digital therapeutics market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on application and end use.

Breakup by Application:

 

 
 

www.imarcgroup.com

Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.

To get more information about this market, Request Sample

  • Diabetes
  • Obesity
  • CVD
  • CNS Disease
  • Respiratory Diseases
  • Smoking Cessation
  • Others
     

Breakup by End Use:

  • Patients
  • Providers
  • Payers
  • Employers
  • Others
     

Breakup by Region:

 

 
 

www.imarcgroup.com

To get more information on the regional analysis of this market, Request Sample

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being 2Morrow Inc., Canary Health Inc., Click Therapeutics Inc., Mango Health Inc. (TrialCard Incorporated), Noom Health Inc., Omada Health Inc., Pear Therapeutics, Inc., Propeller Health (ResMed), Teladoc Health Inc., Voluntis Inc. and WellDoc Inc.

Report Coverage:

Report Features Details
Base Year of the Analysis 2021
Historical Period 2016-2021
Forecast Period 2022-2027
Units US$ Billion
Segment Coverage Application, End Use, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered 2Morrow Inc., Canary Health Inc., Click Therapeutics Inc., Mango Health Inc. (TrialCard Incorporated), Noom Health Inc., Omada Health Inc., Pear Therapeutics, Inc., Propeller Health (ResMed), Teladoc Health Inc., Voluntis Inc. and WellDoc Inc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Digital Therapeutics Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Application
    6.1    Diabetes
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Obesity
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    CVD
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    CNS Disease
        6.4.1 Market Trends
        6.4.2 Market Forecast
    6.5    Respiratory Diseases
        6.5.1 Market Trends
        6.5.2 Market Forecast
    6.6    Smoking Cessation
        6.6.1 Market Trends
        6.6.2 Market Forecast
    6.7    Others
        6.7.1 Market Trends
        6.7.2 Market Forecast
7   Market Breakup by End Use
    7.1    Patients
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Providers
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Payers
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Employers
        7.4.1 Market Trends
        7.4.2 Market Forecast
    7.5    Others
        7.5.1 Market Trends
        7.5.2 Market Forecast
8   Market Breakup by Region
    8.1    North America
        8.1.1 United States
           8.1.1.1 Market Trends
           8.1.1.2 Market Forecast
        8.1.2 Canada
           8.1.2.1 Market Trends
           8.1.2.2 Market Forecast
    8.2    Asia-Pacific
        8.2.1 China
           8.2.1.1 Market Trends
           8.2.1.2 Market Forecast
        8.2.2 Japan
           8.2.2.1 Market Trends
           8.2.2.2 Market Forecast
        8.2.3 India
           8.2.3.1 Market Trends
           8.2.3.2 Market Forecast
        8.2.4 South Korea
           8.2.4.1 Market Trends
           8.2.4.2 Market Forecast
        8.2.5 Australia
           8.2.5.1 Market Trends
           8.2.5.2 Market Forecast
        8.2.6 Indonesia
           8.2.6.1 Market Trends
           8.2.6.2 Market Forecast
        8.2.7 Others
           8.2.7.1 Market Trends
           8.2.7.2 Market Forecast
    8.3    Europe
        8.3.1 Germany
           8.3.1.1 Market Trends
           8.3.1.2 Market Forecast
        8.3.2 France
           8.3.2.1 Market Trends
           8.3.2.2 Market Forecast
        8.3.3 United Kingdom
           8.3.3.1 Market Trends
           8.3.3.2 Market Forecast
        8.3.4 Italy
           8.3.4.1 Market Trends
           8.3.4.2 Market Forecast
        8.3.5 Spain
           8.3.5.1 Market Trends
           8.3.5.2 Market Forecast
        8.3.6 Russia
           8.3.6.1 Market Trends
           8.3.6.2 Market Forecast
        8.3.7 Others
           8.3.7.1 Market Trends
           8.3.7.2 Market Forecast
    8.4    Latin America
        8.4.1 Brazil
           8.4.1.1 Market Trends
           8.4.1.2 Market Forecast
        8.4.2 Mexico
           8.4.2.1 Market Trends
           8.4.2.2 Market Forecast
        8.4.3 Others
           8.4.3.1 Market Trends
           8.4.3.2 Market Forecast
    8.5    Middle East and Africa
        8.5.1 Market Trends
        8.5.2 Market Breakup by Country
        8.5.3 Market Forecast
9   SWOT Analysis
    9.1    Overview
    9.2    Strengths
    9.3    Weaknesses
    9.4    Opportunities
    9.5    Threats
10  Value Chain Analysis
11  Porters Five Forces Analysis

    11.1    Overview
    11.2    Bargaining Power of Buyers
    11.3    Bargaining Power of Suppliers
    11.4    Degree of Competition
    11.5    Threat of New Entrants
    11.6    Threat of Substitutes
12  Price Analysis
13  Competitive Landscape

    13.1    Market Structure
    13.2    Key Players
    13.3    Profiles of Key Players
        13.3.1    2Morrow Inc.
           13.3.1.1 Company Overview
           13.3.1.2 Product Portfolio
        13.3.2    Canary Health Inc.
           13.3.2.1 Company Overview
           13.3.2.2 Product Portfolio
        13.3.3    Click Therapeutics Inc.
           13.3.3.1 Company Overview
           13.3.3.2 Product Portfolio
        13.3.4    Mango Health Inc. (TrialCard Incorporated)
           13.3.4.1 Company Overview
           13.3.4.2 Product Portfolio
        13.3.5    Noom Health Inc.
           13.3.5.1 Company Overview
           13.3.5.2 Product Portfolio
        13.3.6    Omada Health Inc.
           13.3.6.1 Company Overview
           13.3.6.2 Product Portfolio
        13.3.7    Pear Therapeutics, Inc.
           13.3.7.1 Company Overview
           13.3.7.2 Product Portfolio
        13.3.8    Propeller Health (ResMed)
           13.3.8.1 Company Overview
           13.3.8.2 Product Portfolio
        13.3.9    Teladoc Health Inc.
           13.3.9.1 Company Overview
           13.3.9.2 Product Portfolio
        13.3.10    Voluntis Inc.
           13.3.10.1 Company Overview
           13.3.10.2 Product Portfolio
        13.3.11    WellDoc Inc.
           13.3.11.1 Company Overview
           13.3.11.2 Product Portfolio

List of Figures

Figure 1: Global: Digital Therapeutics Market: Major Drivers and Challenges
Figure 2: Global: Digital Therapeutics Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Digital Therapeutics Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Digital Therapeutics Market: Breakup by Application (in %), 2021
Figure 5: Global: Digital Therapeutics Market: Breakup by End Use (in %), 2021
Figure 6: Global: Digital Therapeutics Market: Breakup by Region (in %), 2021
Figure 7: Global: Digital Therapeutics (Diabetes) Market: Sales Value (in Million US$), 2016 & 2021
Figure 8: Global: Digital Therapeutics (Diabetes) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 9: Global: Digital Therapeutics (Obesity) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Digital Therapeutics (Obesity) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Digital Therapeutics (CVD) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Digital Therapeutics (CVD) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Digital Therapeutics (CNS Disease) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Digital Therapeutics (CNS Disease) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Digital Therapeutics (Respiratory Diseases) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Digital Therapeutics (Respiratory Diseases) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Digital Therapeutics (Smoking Cessation) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Digital Therapeutics (Smoking Cessation) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Digital Therapeutics (Other Applications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Digital Therapeutics (Other Applications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Digital Therapeutics (Patients) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Digital Therapeutics (Patients) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Digital Therapeutics (Providers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Digital Therapeutics (Providers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Global: Digital Therapeutics (Payers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Global: Digital Therapeutics (Payers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Global: Digital Therapeutics (Employers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Global: Digital Therapeutics (Employers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Global: Digital Therapeutics (Other End Users) Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Global: Digital Therapeutics (Other End Users) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: North America: Digital Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: North America: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: United States: Digital Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: United States: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Canada: Digital Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Canada: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: Asia-Pacific: Digital Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: Asia-Pacific: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: China: Digital Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: China: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: Japan: Digital Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: Japan: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: India: Digital Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: India: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: South Korea: Digital Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: South Korea: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: Australia: Digital Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: Australia: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: Indonesia: Digital Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: Indonesia: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: Others: Digital Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: Others: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: Europe: Digital Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: Europe: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: Germany: Digital Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: Germany: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: France: Digital Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: France: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: United Kingdom: Digital Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: United Kingdom: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: Italy: Digital Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: Italy: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: Spain: Digital Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: Spain: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: Russia: Digital Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: Russia: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: Others: Digital Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: Others: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: Latin America: Digital Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: Latin America: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: Brazil: Digital Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: Brazil: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: Mexico: Digital Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 74: Mexico: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: Others: Digital Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 76: Others: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Middle East and Africa: Digital Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 78: Middle East and Africa: Digital Therapeutics Market: Breakup by Country (in %), 2021
Figure 79: Middle East and Africa: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 80: Global: Digital Therapeutics Industry: SWOT Analysis
Figure 81: Global: Digital Therapeutics Industry: Value Chain Analysis
Figure 82: Global: Digital Therapeutics Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Digital Therapeutics Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Digital Therapeutics Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 3: Global: Digital Therapeutics Market Forecast: Breakup by End Use (in Million US$), 2022-2027
Table 4: Global: Digital Therapeutics Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 5: Global: Digital Therapeutics Market: Competitive Structure
Table 6: Global: Digital Therapeutics Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Key Questions Answered in This Report

The global digital therapeutics market was valued at US$ 4.2 Billion in 2021.

We expect the global digital therapeutics market to exhibit a CAGR of 21.7% during 2022-2027.

The growing adoption of advanced medical solutions to enhance existing medical treatments, offer
personalized physiological parameters, minimize reliance on pharmaceuticals, etc., is primarily driving
the global digital therapeutics market.

The sudden outbreak of COVID-19 pandemic has led to the increasing adoption of digital therapeutics
across several healthcare facilities for efficiently managing high patient influx, optimizing patient care,
and providing remote medical care solutions.

Based on the application, the global digital therapeutics market has been segmented into diabetes,
obesity, CVD, CNS disease, respiratory diseases, smoking cessation, and others. Currently, diabetes holds
the majority of the total market share.

Based on the end use, the global digital therapeutics market can be divided into patients, providers,
payers, employers, and others. Among these, patients exhibit a clear dominance in the market.

On a regional level, the market has been classified into North America, Asia Pacific, Europe, Latin
America, and Middle East and Africa, where North America currently dominates the global market.

Some of the major players in the global digital therapeutics market include 2Morrow Inc., Canary Health
Inc., Click Therapeutics Inc., Mango Health Inc. (TrialCard Incorporated), Noom Health Inc., Omada
Health Inc., Pear Therapeutics, Inc., Propeller Health (ResMed), Teladoc Health Inc., Voluntis Inc., and
WellDoc Inc.

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links